In an industrial collaboration project, TU Wien has developed a medication that can alleviate or even completely eliminate the symptoms of celiac disease. It should be available as early as 2021.
Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.
Although efforts are already being made to treat celiac disease, the proposed drugs have an effect on the immune system. Possible side effects must therefore be examined very carefully. Although initial clinical studies are underway, they will not lead to a marketable product in the next few years.
For this reason, an entirely different approach has been pursued at TU Wien in collaboration with the industrial partner Sciotech Diagnostic Technologies GmbH. Instead of developing a drug that interferes with the immune system, TU Wien has created a simple medical product that directly attacks the gluten molecules to render them harmless. This makes the approval process much simpler, meaning that the product should be available in ordinary pharmacies as early as 2021.
Molecules like keys and locks
“Our bodies produce antibodies that fit intruding antigens precisely, like a key to a lock. This immune response makes these antigens harmless,” explains Professor Oliver Spadiut, head of the Integrated Bioprocess Development Research Group at TU Wien. “If a new antibody fragment is found and produced that docks to and blocks the invading gluten molecule without triggering the immune system, the symptoms of celiac disease can be suppressed.”
The aim of the research project was therefore to produce a complex of two such antibody fragments that envelop the gluten molecule at a molecular level, so that it can no longer have any further effects in the intestines.
To do this, certain bacteria have to be reprogrammed so that they produce exactly the desired antibody fragment. “The formation of such proteins in a bacterium is a highly complicated process,” explains Oliver Spadiut. “It can easily happen that the proteins are not folded exactly as we want.” Instead of the desired antibody fragments, so-called “inclusion bodies” are formed – small particles consisting of incorrectly folded proteins. A process therefore had to be developed to refold these inclusion bodies and to obtain the desired proteins from them.
Such processes, in which the folding of proteins is specifically altered, have not yet been studied in great detail and so they are not very efficient. “You have to precisely understand the chemical processes involved and intervene in a complicated way,” says Oliver Spadiut. “It has therefore taken a while, but we have now developed a process that can be easily reproduced, can be scaled up to industrial application and delivers a very good yield of the desired product”
In pharmacies soon
The project was supported by the industrial partner SCIOTEC Diagnostic Technologies GmbH, who will now bring the new medical product to the market. “It will be a preparation that celiac patients can take together with gluten-containing foods to alleviate coeliac symptoms,” explains Oliver Spadiut. “It remains to be seen whether the symptoms will disappear completely or will only be alleviated. The precise effects will probably vary from person to person.
Learn more: A new remedy for celiac disease
The Latest on: Celiac disease
via Google News
The Latest on: Celiac disease
- The Poop About Your Gut Health and Personalized Nutritionon August 26, 2021 at 4:00 am
Researchers are coming around to the idea that there isn't a one-size-fits-all diet. Some companies are going further to find out what fits you, specifically.
- Celiac Disease Foundation Welcomes the Newly Created Bipartisan Congressional Celiac Disease Caucuson August 24, 2021 at 1:02 am
Congresswoman Betty McCollum (DFL-Minn.) launched the Congressional Celiac Disease Caucus, along with U.S. Representatives Jake Auchincloss (D-MA), Earl Blumenauer (D-OR), Matt Cartwright (D-PA), ...
- Specially designed monoclonal antibodies may prevent celiac disease, study findson August 20, 2021 at 11:00 am
Antibody therapy may help prevent the development of celiac disease, the digestive disorder that limits the body's ability to process foods containing wheat, barley and rye, a study published by ...
- Gluten Sensitivity Can Cause Celiac Disease, Here's How It Is Diagnosed and Treatedon August 20, 2021 at 9:27 am
Gluten rich food can be trigger for celiac disease. Read to know about diagnosis and treatment options available for this disease.
- Study: High lifetime risk of celiac disease in Swedenon August 20, 2021 at 4:27 am
In a nationwide study of more than 44,000 patients with celiac disease and 412,000 individuals with a normal small intestinal mucosa, researchers at Karolinska Institutet, Sweden, Calgary University ...
- Should You Go Gluten Free If You Have Inflammatory Bowel Disease?on August 18, 2021 at 11:41 am
If you have IBD, eliminating gluten from your diet could help improve symptoms such as abdominal pain and diarrhea. Here’s what to know.
- Raleigh firm's drug could help fight rare Covid-related syndrome in childrenon August 18, 2021 at 11:32 am
As Covid-19 cases rise among children, a celiac treatment developed in Raleigh may hold answers to treating a rare, potentially deadly syndrome linked to the disease.
- Shattering the Myth: The Gluten-Free Diet Isn’t Enough to Treat Celiac Diseaseon August 16, 2021 at 8:57 am
The gluten-free diet is currently the only treatment for celiac disease, but it is far from a complete and effective intervention. That’s the message Beyond Celiac, the leading catalyst for a celiac ...
- 20 things to know about celiac diseaseon August 14, 2021 at 11:12 am
Celiac disease is hereditary. People who have a parent, a child, or a sibling with the disorder are up to 20 percent more likely to be diagnosed with celiac disease, according to a 2005 American ...
via Bing News